The Patent Finder

Terms ending in 2038

Atea Pharmaceuticals, Inc.

Every in-force patent on Atea Pharmaceuticals, Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,894,804Nucleotide Hemi-Sulfate Salt for the Treatment of Hepatitis C Virus
In force
 · Low confidence
Atea Pharmaceuticals, Inc.In forceLow confidence
US 10,906,928Nucleotide Hemi-Sulfate Salt for the Treatment of Hepatitis C Virus
In force
 · Low confidence
Atea Pharmaceuticals, Inc.In forceLow confidence
US 11,690,860Treatment of HCV Infected Patients with Cirrhosis
In force
 · Low confidence
Atea Pharmaceuticals, Inc.In forceLow confidence
US 12,006,340Nucleotide Hemi-Sulfate Salt for the Treatment of Hepatitis C Virus
In force
 · Medium confidence
Atea Pharmaceuticals, Inc.In forceMedium confidence
US 12,741,984Nucleotide Hemi-Sulfate Salt for the Treatment of Hepatitis C Virus
In force
 · High confidence
Atea Pharmaceuticals, Inc.In forceHigh confidence
US 10,519,186Nucleotide Hemi-Sulfate Salt for the Treatment of Hepatitis C Virus
In force
 · High confidence
Atea Pharmaceuticals, Inc.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited